[go: up one dir, main page]

AU1660399A - Pharmaceutical preparations - Google Patents

Pharmaceutical preparations

Info

Publication number
AU1660399A
AU1660399A AU16603/99A AU1660399A AU1660399A AU 1660399 A AU1660399 A AU 1660399A AU 16603/99 A AU16603/99 A AU 16603/99A AU 1660399 A AU1660399 A AU 1660399A AU 1660399 A AU1660399 A AU 1660399A
Authority
AU
Australia
Prior art keywords
pentaerythritol
pharmaceutical preparations
dinatrate
pentaerythrito
petn
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU16603/99A
Inventor
Sabine Freitag
Ulrich Gunther
Ulrike Kuntze
Wilhelm Thomas Lehr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Puren Pharma GmbH and Co KG
Original Assignee
Isis Pharma GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Isis Pharma GmbH filed Critical Isis Pharma GmbH
Publication of AU1660399A publication Critical patent/AU1660399A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The invention relates to new, in particular orally administered pharmaceutical preparations containing, as pharmaceutical agent, pentaerythritol tetranitrate (PETN) or its metabolites pentaerythritol trinitrate, pentaerythritol dinatrate and pentaerythrito mononitrate, in amounts which guarantee the patient a sufficient dosage with one administering (per day).
AU16603/99A 1997-10-16 1998-10-16 Pharmaceutical preparations Abandoned AU1660399A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19745618 1997-10-16
DE19745618 1997-10-16
PCT/DE1998/003030 WO1999018930A2 (en) 1997-10-16 1998-10-16 Pharmaceutical preparations

Publications (1)

Publication Number Publication Date
AU1660399A true AU1660399A (en) 1999-05-03

Family

ID=7845649

Family Applications (1)

Application Number Title Priority Date Filing Date
AU16603/99A Abandoned AU1660399A (en) 1997-10-16 1998-10-16 Pharmaceutical preparations

Country Status (12)

Country Link
EP (1) EP1023059B1 (en)
AT (1) ATE313323T1 (en)
AU (1) AU1660399A (en)
CZ (1) CZ301265B6 (en)
DE (3) DE29880094U1 (en)
DK (1) DK1023059T3 (en)
ES (1) ES2255193T3 (en)
HU (1) HUP0100634A3 (en)
PL (1) PL340386A1 (en)
SK (1) SK284769B6 (en)
WO (1) WO1999018930A2 (en)
ZA (1) ZA989356B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999067430A2 (en) * 1998-06-24 1999-12-29 Alpharma-Isis Gmbh & Co. Kg Analytic substrates and antioxidative agents
DE102008050597A1 (en) 2008-10-09 2010-04-15 Actavis Deutschland Gmbh & Co. Kg Preparation, useful for treating and preventing idiopathic sudden sensorineural hearing loss, comprises pentaerythritol tetra-, pentaerythritol trinitrate, pentaerythritol dinitrate or pentaerythritol mononitrate, and an excipient

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3028307A (en) * 1959-05-27 1962-04-03 Warner Lambert Pharmaceutical Pre-dried granulation and production of sublingual compressed organic nitrate tablets with selected solubilizing agents
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
ATE49503T1 (en) * 1982-09-29 1990-02-15 Ici America Inc MEDICINAL COMPOSITIONS CONTAINING ORGANIC NITRATES STABLE TO DETONATION BY FIRE.
DE3328094A1 (en) * 1983-08-04 1985-02-21 H. Trommsdorff GmbH & Co, 5110 Alsdorf Desensitised pharmaceutical formulation of explosive nitric acid esters
ATE89164T1 (en) * 1989-02-20 1993-05-15 Soorianarain Baligadoo PHARMACEUTICAL CARDIAC PROTECTIVE COMPOSITIONS CONTAINING AMIODARONE, A NITRODERIVATE, NAMELY ISOSORBIDE DINITRATE, AND AN OPTIONAL BETA BLOCKER.
US5278192A (en) * 1992-07-02 1994-01-11 The Research Foundation Of State University Of New York Method of vasodilator therapy for treating a patient with a condition
DE4410997A1 (en) * 1994-03-30 1995-10-26 Isis Pharma Gmbh Pharmaceutical preparations and drugs for the prevention and treatment of endothelial dysfunctions

Also Published As

Publication number Publication date
DE19847781A1 (en) 1999-04-22
EP1023059B1 (en) 2005-12-21
HUP0100634A2 (en) 2001-07-30
DE29880094U1 (en) 2000-05-18
DE59813300D1 (en) 2006-01-26
WO1999018930A3 (en) 1999-10-07
CZ20001342A3 (en) 2000-09-13
DK1023059T3 (en) 2006-04-24
ES2255193T3 (en) 2006-06-16
SK5382000A3 (en) 2000-11-07
PL340386A1 (en) 2001-01-29
WO1999018930A2 (en) 1999-04-22
SK284769B6 (en) 2005-11-03
EP1023059A2 (en) 2000-08-02
CZ301265B6 (en) 2009-12-23
ZA989356B (en) 1998-11-16
ATE313323T1 (en) 2006-01-15
HUP0100634A3 (en) 2003-07-28

Similar Documents

Publication Publication Date Title
CA2170255A1 (en) Pharmaceutical Composition for Immunoenhancement Therapy
MY124695A (en) Novel composition and use.
MX9505182A (en) Therapeutical composition for topical application, containing a p substance antagonist.
ZA962536B (en) Pharmaceutical composition for transdermal administration.
AU3435497A (en) Autocross-linked hyaluronic acid and related pharmaceutical compositions for the treatment of arthropathies
AU1890295A (en) Piperidines and pyrrolidines
AU646230B2 (en) Pharmaceutical compositions and methods for treating the symptoms of overindulgence
TW261615B (en)
UA39101C2 (en) derivatives of 11<font face="Symbol">b</font>-benzaldoxym-extra-4,9-dien, method for the preparation thereof and pharmaceutical composition with antiprogestin activity
WO1994008613A3 (en) Use of parathormone, of its biologically active fragments and of related peptides for treatment of pregnancy
BG105570A (en) Pharmaceutical compositions for modified release insulin sensitiser
HUP0203721A2 (en) Novel hormonal composition and the use thereof
AU1660399A (en) Pharmaceutical preparations
CA2218643A1 (en) Oral pharmaceutical composition of piperidinoalkanol compounds in solution form
CO4940457A1 (en) PHARMACEUTICAL COMPOSITIONS INCLUDING INSULIN SENSITIZERS FOR THE TREATMENT OF DIABETES
AR019331A2 (en) PHARMACEUTICAL COMPOSITION CONTAINING AN INSULIN SENSITIZER AND AN INSULIN SECRETAGOG.
GR1002576B (en) Pharmaceutical compositions and a process for the preparation thereof.
AU7028598A (en) Combined preparation of 2-methylthiazolidine-2,4-dicarboxylic acid and paracetamol
MY115795A (en) Substituted benzenesulfonylureas and -thioureas, processes for their preparation and use of pharmaceutical preparations based on these compounds, and medicaments containing them
UA32583C2 (en) Derivatives of arylthioalkylthiopyridine
AU6404798A (en) Pharmaceutical composition for the administration of thiocolchicoside via the buccal mucosa
AU2053195A (en) Tablet, capsule, or granule comprising desogestrel
AU2624499A (en) Oral compositions at low dosage of cytotoxic proteins
KR960037051A (en) Anticancer Therapeutic Composition for Combination Administration of Cisplatin with Aloesin
IL114646A0 (en) Method of inhibiting leukotriene biosynthesis

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase